Cell Line : ISHIKAWA(HERAKLIO)02ER-
Cellosaurus Index : CVCL_6543
Cellosaurus ID : ISHIKAWA(HERAKLIO)02ER-
CTRP1 Name
, CTRP2 Name
: ISHIKAWAHERAKLIO02ER
CCLE Name
: ISHIKAWAHERAKLIO02ER_ENDOMETRIUM
Cancer Type : endometrium
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| ISHIKAWA(HERAKLIO)02ER- | (-)-gallocatechin-3-monogallate | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | 1-methyl-DL-tryptophan | CTRP1 | 0.1303 | 16.6670 |
|
| ISHIKAWA(HERAKLIO)02ER- | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | 2-bromopyruvate | CTRP1 | 0.2603 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | 2-deoxyglucose | CTRP1 | 0.2890 | 37.0080 |
|
| ISHIKAWA(HERAKLIO)02ER- | 2-fluoropalmitic acid | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.0027 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 3-chloro-L-alanine | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | 4-IPP | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 4-methylfasudil | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 5-benzyl-9-tert-butyl-paullone | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 6-diazo-5-oxo-L-norleucine | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 6-methoxyharmalan | CTRP1 | 0.2430 | 31.1140 |
|
| ISHIKAWA(HERAKLIO)02ER- | 6-NBDG | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 7-nitroindazole | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AA-COCF3 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ABH | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ABT-751 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ABT737 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AGK-2 | CTRP2,CTRP1 | 0.0041 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Alda-1 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | alpha-cyano-4-hydroxycinnamic acid | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | AM-580 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | aspirin | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | avrainvillamide | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | batimastat | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Bax channel blocker | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BEC | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BI-2536 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BIBR-1532 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | bistramide A | CTRP1 | 0.2517 | 32.2330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BIX-01294 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BIX-01338 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | blebbistatin | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BML-259 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-191011 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-299897 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-536924 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-641988 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BMS-754807 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Bortezomib | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | bovinocidin | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K02492147 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K03911514 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K13999467 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K27986637 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K37390332 | CTRP2 | 0.0010 | 17.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K58730230 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K75293299 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K84807411 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD-K99584050 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD1812 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD2649 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD2662 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD4770 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD55319 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD63610 | CTRP1 | 0.0027 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD6368 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD7137 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD8958 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD9786 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | BX795 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Cabozantinib | CTRP2 | 0.0020 | 4.2000 |
|
| ISHIKAWA(HERAKLIO)02ER- | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | capsaicin | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CCT036477 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CD-1530 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | chaetocin | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CHEMBL399379 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CID 2853753 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| ISHIKAWA(HERAKLIO)02ER- | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 10b | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 110 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 12 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 2 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 4 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 44 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | cyanoquinoline 11 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | cytosporone B | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Dactolisib | CTRP1 | 0.1303 | 16.6670 |
|
| ISHIKAWA(HERAKLIO)02ER- | dalcetrapib | CTRP1 | 0.2587 | 33.1000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Daporinad | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | DG-041 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | dichloroacetic acid | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | DL-TBOA | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | eflornithine | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| ISHIKAWA(HERAKLIO)02ER- | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | endo-IWR-1 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Entinostat | CTRP2 | 0.0160 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ethylidene glucose | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Etoposide | CTRP2,CTRP1 | 0.0009 | 28.3180 |
|
| ISHIKAWA(HERAKLIO)02ER- | fatostatin | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Fedratinib | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | FGIN-1-27 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | fluoropyruvate | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Flutamide | CTRP1 | 0.1887 | 24.1360 |
|
| ISHIKAWA(HERAKLIO)02ER- | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | FMK-PA | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | fosfomycin | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Fulvestrant | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | fumagillol | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Gemcitabine | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | glibenclamide | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Gly-Gly-PALO | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GW-405833 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | GW843682X | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | HA-1004 | CTRP1 | 0.4440 | 56.8160 |
|
| ISHIKAWA(HERAKLIO)02ER- | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | HLI 373 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | idarubicin | CTRP1 | 0.0027 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | irosustat | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | iso-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | isoevodiamine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | isoliquiritigenin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | IWP-2 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0081 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 12.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 12.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | JZL-184 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | kinetin riboside | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Ko-143 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | L-685458 | CTRP2,CTRP1,CCLE | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | LDN-193189 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | LE-135 | CTRP2,CTRP1 | 0.0020 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Lenalidomide | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | leucascandrolide A | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | LFM-A13 | CTRP1 | 0.3617 | 46.2960 |
|
| ISHIKAWA(HERAKLIO)02ER- | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Linsitinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | lonidamine | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | losartan | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | LY-2365109 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | m-3M3-FBS | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | manumycin A | CTRP2,CTRP1 | 0.0009 | 30.2680 |
|
| ISHIKAWA(HERAKLIO)02ER- | maraviroc | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Masitinib | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | mitomycin | CTRP2,CTRP1 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | MK-1775 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | MK-591 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML006 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML007 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML013 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML037 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML038 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML039 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML050 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML052 | CTRP1 | 0.1303 | 16.6670 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML090 | CTRP1 | 0.1303 | 16.6670 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML100 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML101 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML150 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML159 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML160 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML162 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML203 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | myriocin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | N-oxalyl-D-phenylalanine | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | N5-iminoethyl-L-ornithine | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | N9-isopropylolomoucine | CTRP2,CTRP1 | 0.0120 | 400.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Navitoclax | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | neopeltolide | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | neratinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | nifedipine | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NSC23766 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NSC632839 | CTRP2,CTRP1 | 0.0020 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | NSC95397 | CTRP2,CTRP1 | 0.0010 | 53.6960 |
|
| ISHIKAWA(HERAKLIO)02ER- | Nutlin-3a | CTRP1,CCLE | 0.0025 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NVP-AUY922 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Olaparib | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | orteronel | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | OSW-1 | CTRP1 | 0.0027 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | oxythiamine | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | P-0850 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PAC-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | panduratin A | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | parbendazole | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Parthenolide | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PDMP | CTRP1 | 0.0260 | 3.3333 |
|
| ISHIKAWA(HERAKLIO)02ER- | Pemetrexed | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Pevonedistat | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PF-04217903 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PF-3845 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | phloretin | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PI-103 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | pifithrin-alpha | CTRP2,CTRP1 | 0.0071 | 230.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PIK-75 | CTRP1 | 0.0030 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PIK-90 | CTRP1 | 0.1303 | 16.6670 |
|
| ISHIKAWA(HERAKLIO)02ER- | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Piperlongumine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 4.2000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PK-11195 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | pluripotin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PNU-74654 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PP-30 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PRIMA-1MET | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PT-630 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | purmorphamine | CTRP2,CTRP1 | 0.0046 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | quinoclamine | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | racemic-2,4-dideoxy-DC-45-A2 | CTRP1 | 0.0030 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Rapamycin | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | RepSox | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Ro-28-1675 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | rosiglitazone | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | rotenone | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | RS-23597-190 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Selumetinib | CTRP2,CTRP1,CCLE | 0.0025 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Sepantronium bromide | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Serdemetan | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | sildenafil | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SKI-II | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SN-38 | CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SNX-2112 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | sparfosic acid | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Staurosporine | CTRP2 | 0.0001 | 3.3000 |
|
| ISHIKAWA(HERAKLIO)02ER- | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | SU11274 | CTRP2 | 0.0020 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | T-5345967 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tamatinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Tamoxifen | CTRP2,CTRP1 | 0.0030 | 100.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Tanespimycin | CTRP2,CTRP1,CCLE | 0.0010 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Telomerase Inhibitor IX | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Teniposide | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | TGX-115 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | tipifarnib-P2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Tivozanib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tosedostat | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Tozasertib | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | trans-C 75 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | Tretinoin | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | triacsin C | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | triptolide | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | TTNBP | CTRP1 | 0.0260 | 3.3333 |
|
| ISHIKAWA(HERAKLIO)02ER- | Tubastatin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | tyrphostin AG-1478 | CTRP1 | 0.3697 | 47.3200 |
|
| ISHIKAWA(HERAKLIO)02ER- | ubistatin B | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | UNC0638 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | ursolic acid | CTRP1 | 0.1140 | 14.5970 |
|
| ISHIKAWA(HERAKLIO)02ER- | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Vismodegib | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | Vorinostat | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | WT-161 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | XAV939 | CTRP1 | 0.2890 | 37.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | YM-022 | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | zebularine | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| ISHIKAWA(HERAKLIO)02ER- | zileuton | CTRP1 | 0.2603 | 33.3330 |
|
| ISHIKAWA(HERAKLIO)02ER- | ZM336372 | CTRP1 | 0.3343 | 42.7960 |
|
| ISHIKAWA(HERAKLIO)02ER- | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC